Atlas Trials

Bioavailability of Clormadinone/Ethinyl Estradiol Tablets 2 mg/0.02 mg With Regards to Reference Product

Clinical trial NCT04713904 · COMPLETED

Trial details

NCT number
NCT04713904
Sponsor
Laboratorios Andromaco S.A.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalence
Start date
2021-01-16
Primary completion
2021-01-16
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.